bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.06.11.658620

Breaking Through Biology's Data Wall: Expanding the Known Tree of Life by Over 10x using a Global Biodiscovery Pipeline

Abstract

Advancements in the life sciences have always been built upon our collective understanding of life on Earth. Now, the rise of generative biology - the use of AI foundation models to design, generate, and annotate proteins, pathways and therapeutics - is creating unprecedented demand for large, diverse biological sequence datasets. While a limited subset of such data can be generated in clinical or laboratory settings, the vast majority of the training data for unsupervised models must be sourced from the natural world - the product of nearly four billion years of evolutionary history. However, the public databases that currently supply this data, while foundational to research, were established to aggregate results from academic experiments, not as training datasets for machine learning. Their human-centric data structure limits model performance due to redundancy, taxonomic and geographic bias, limited biological context, and inconsistent provenance. With 68% of all sequence data in the SRA database coming from just 5 species, this is one of the most severe class imbalance problems ever encountered in AI. Legal and infrastructural constraints further exacerbate this bottleneck. To address these limitations and support scalable model training, we introduce BaseData: the largest and fastest-growing biological sequence database ever built, and the first purpose-built for training foundation models. As of late 2024, BaseData contained 9.8 billion novel genes, representing more than a 10-fold expansion in known protein diversity after accounting for redundancy. BaseData also contains more than 1 million species not represented in other genomic databases. Its partnership-driven data supply chain across 26 countries and autonomous regions enables growth of up to 2 billion novel genes per month, far exceeding public repositories. All data is collected under benefit sharing agreements using standardized protocols and structured using graph-based, ontology-rich metadata that preserves evolutionary context. BaseData represents a new, ethically-grounded infrastructure for training biological foundation models, complementing public efforts and enabling the next era of generative biology. Short AbstractProgress of AI in biology is now being limited by the availability of high-quality biological sequence data from nature. To get past this data wall, we introduce BaseData, a new biological database built on top of a global, scalable biodiscovery pipeline. As of 2024, BaseData had already expanded the known protein universe by over 10x.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vince, O., Oldach, P., Pereno, V., Leung, M. H. Y., Greco, C., Minto-Cowcher, G., Ur-Rehman, S., Kam, K. Y. K., Chow, W., Bolton, E., Mwambingu, B. R., Greenhalgh, N. L., Knot, I. E., Christoffersen, L., Clark, M., Pecoraro, R., Kollasch, A. W., Bohnuud, T., Bakalar, M., Lorenz, P., Gowers, G.. 2025-06-14. Breaking Through Biology's Data Wall: Expanding the Known Tree of Life by Over 10x using a Global Biodiscovery Pipeline. https://doi.org/10.1101/2025.06.11.658620

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Structural variation in repeat elements is widespread in normal human tissues and in tumorigenesis

Somatic mosaicism contributes to genomic variation, yet postzygotic structural variants remain under-characterized. We performed long- and short-read WGS from multiple individuals (n=47 normal tissues; n=168 samples) and identified mosaic structural variants in all individuals and germ layers, impacting a median 285.2 kb/genome. Nearly half of breakpoints were independently validated, with tissue distributions reflecting both early and late developmental origins. Most mosaic variants were repeat-mediated and 8.3% overlapped functional elements, an enrichment compared to germline variants. To extend these analyses in samples where long-read sequencing is infeasible, we measured repeat alterations from short-read sequencing, recapitulating mosaic tissue-specific differences. We characterized tumor- and tissue- specific variation in repeats across 15 cancer types and found tumor-related repeat variation to be similar in scale to that of normal mosaic variation. Tracking repeat changes in cell-free DNA provided a noninvasive approach for tumor monitoring. Our analyses revealed widespread repeat-driven structural variation in health and disease.

genomics↗

RNA isoform-resolved multiplexed sequencing with bioorthogonal barcoding

RNA isoform dysregulation drives disease pathogenesis and is the target of FDA-approved splice-switching therapeutics. However, multiplexed sequencing methods discard splice junction information because only 3' termini are barcoded and counted. Here, we repurpose acylation and click chemistries to conjugate bioorthogonal barcodes (bobcodes) directly onto multiple internal positions along cellular RNAs. Bobcoded RNAs from multiple samples are pooled for multiplexed cDNA synthesis, during which reverse transcriptase switches from each RNA template onto its tethered bobcode with greater than 99% accuracy in species mixing experiments. Bobcode attachment intervals set cDNA insert sizes without a library fragmentation step, and priming with poly(dT) or random hexamers selects between 3'-end counting and full-length isoform capture. A bioorthogonal barcode-sequencing (BOB-seq v0.1) drug screen identifies transcriptome-wide on- and off-target RNA splicing effects and outperforms existing multiplexing RNA sequencing methods in workflow simplicity, sample-to-sample variability, and barcoding accuracy. Bobcodes add isoform resolution to scalable multiplexed RNA sequencing.

genomics↗

Structural polymorphism and population-variable coding capacity of HERV-K(HML-2) in human pangenomes

Approximately 8% of the human genome is derived from ancient retroviral infections. The most recently integrated of these endogenous retroviruses is the HERV-K(HML-2) clade, whose expression has been associated with cancer, amyotrophic lateral sclerosis, and embryogenesis. Studies of HERV expression, particularly HML-2, have relied predominantly on short-read sequencing. However, the high similarity among HML-2 proviruses prevents many short reads from being assigned uniquely to individual loci. We therefore compared haplotype-resolved long-read genome assemblies from 292 donors to resolve variation in proviral structure and coding capacity. Several loci previously thought to be fixed were structurally polymorphic. Tandem arrays occurred at 13 loci and contained up to six proviral copies in a single array. At 8q11.23, we identified a previously undescribed full-length provirus in one haplotype. All 583 other haplotypes carried a solo-LTR. We found that standard reference genomes failed to represent the coding capacity retained in many individuals, whose proviruses contained intact open reading frames despite disruptive mutations in the reference sequences. Short-read genotypes left 32.5% of the tested donor-variant pairs unresolved at sites associated with viral reading frames. These findings show why HML-2 expression must be interpreted in the context of the structural and coding alleles each individual carries.

genomics↗